Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Ioannina – page 7

185 clinical trials in Ioannina, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ioannina at a glance
185
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

185 trials in Ioannina

Open in trial search

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Non-small cell lung cancer

Not yet recruiting

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Immunitybio Inc.

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Interstitial lung disease+1

Not yet recruiting

A Phase 2 Study Evaluating the Safety and Efficacy of Oral NS-863 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:Ns Pharma Inc.

Sepsis

Not yet recruiting

Clarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Clarithromycin
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Interstitial lung disease+2

Not yet recruiting

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Infection prophylaxis

Not yet recruiting

Study of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Octapharma Pharmazeutika Produktionsgesellschaft mbH

Bacterial infection+1

Not yet recruiting

A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Regeneron Pharmaceuticals Inc.

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Ioannina

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Studies evaluating new combination therapies and investigating methods to reduce cardiovascular risks.

  • Heart Failure Prevention
  • Cardiovascular Disease Management
  • Deep Vein Thrombosis

Multiple trials exploring the effectiveness of novel medications in reducing cardiovascular events and improving patient outcomes.

02 Metabolic Disorders

Innovative research targeting obesity and various forms of hypercholesterolemia. Studies include treatments for both adult and pediatric patients with metabolic conditions.

  • Obesity Management
  • Dyslipidemia Treatment
  • Familial Hypercholesterolemia

Clinical investigations focusing on new therapeutic approaches for managing metabolic disorders and their complications.

03 Respiratory Medicine

Advanced studies in asthma and pulmonary fibrosis treatment. Research evaluating new medications for improving lung function and managing severe respiratory conditions.

  • Asthma Control
  • Pulmonary Fibrosis
  • Viral Lung Infections

Trials examining innovative therapies for both acute and chronic respiratory conditions.

04 Hematology

Research focusing on sickle cell disease and beta-thalassemia. Studies evaluating treatments for blood disorders and related complications.

  • Sickle Cell Disease Treatment
  • Iron Overload Management
  • Multiple Myeloma

Comprehensive trials investigating new therapeutic approaches for various blood disorders.

05 Neurological Conditions

Studies investigating treatments for multiple sclerosis and stroke prevention. Research focused on improving neurological outcomes and disease management.

  • Multiple Sclerosis
  • Stroke Prevention
  • Neurological Disorders

Trials evaluating innovative therapies for managing chronic neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.